Investigational New Drug (IND)
Definition
An Investigational New Drug application is a US regulatory submission that permits eligible clinical investigation of a drug under the IND framework; it is not marketing approval.
By PurePeptideHub Editorial Team · Updated . Educational source review; independent clinical review pending.
Application versus medicine
IND names a regulatory mechanism, not a chemical class. FDA describes the submission as including information on preclinical work, manufacturing and proposed clinical investigation. A compound can be under investigation without having demonstrated that it works for the intended condition.
References: [1]
How to interpret a trial claim
If a company cites an IND or a registered trial, check the sponsor, exact intervention, population and trial phase. A registry entry describes planned or ongoing work; results must be read separately. Permission to investigate does not turn a vendor’s similarly named product into the studied medicine.
Why product-specific examples age quickly
Regulatory status changes over time and can differ between countries, products and indications. Use a dated official record for a specific drug instead of treating an old list of investigational compounds as current approval guidance.